With increasing cases of disinformation across social media blurring the lines of what’s credible and real, how can pharma break through the noise and build back public trust?
Michelle Bridenbaker, RN, MBA
Advertisement
Chief operating officer of Unbiased Science, a Vital Statistics Consulting company.
Articles by Michelle Bridenbaker, RN, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pharma Collaborations Focused on Advancing Antibody-Drug Conjugates and Delivering Treatments for Autoimmune Diseases
2
What Impact will TrumpRx and Other DTC Programs Have on Drug Availability?
3
Roundup: Biopharmaceutical Industry Activity Accelerates with Focus on Rare Diseases and Novel Therapies
4
Roundup: Biopharma Funding Rounds Advance Clinical Development of Novel Therapy and Treatment Solutions
5
